Higgerty Law is currently retaining clients in relation to the Oxycontin class action. The class action was filed on behalf of all persons in Canada who were prescribed and ingested Oxycontin against the manufacturers of the drug, Purdue Pharma, Purdue Pharma Inc., Purdue Frederick Inc., The Purdue Frederick Company Inc., and Purdue Pharma LP.
In 1996, Health Canada approved the drug as a prescription opioid. OxyContin was marketed as an effective, long-lasting and powerful narcotic with the ability to relieve severe pain for up to 12 hours. Purdue Pharma billed the drug as being less addictive, less subject to abuse, and less likely to produce withdrawal symptoms compared to similar pain medications.
Despite the Defendants’ marketing, OxyContin comes with a risk of life-changing negative consequences. OxyContin has the ability to produce drug dependency. Those who take the drug repeatedly can rapidly develop a tolerance to it. Such patients require progressively larger and more frequent doses to cover their underlying pain.
The fallout of Purdue Pharma’s dishonesty in the marketing of OxyContin became publicly known in May 2007, when the company and three of its current and former executives pleaded guilty to criminal charges that it had misled doctors and patients when it claimed the drug was less likely to be abused than traditional narcotics.
If you were prescribed OxyContin you may be eligible for participation in this Class Action. We are currently retaining eligible clients, and would like to hear further from you.
Please contact our firm at 403-503-8888 or [email protected] for further information, or complete the form below. Be advised that completion of the below form does not automatically register you for the lawsuit nor does it mean that you have retained our firm or that we represent you, but rather is an initial point-of-contact tool. A member of our team will be happy to follow up with you further by telephone or e-mail.
These allegations have not yet been proven in a court of law.